Found 15 matching trials
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome PHASE2 Cushing Syndrome is an endocrine disorder causing an over production of the...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
68Ga-DOTATATE PET Scan in Neuroendocrine Cancer PHASE2 Neuroendocrine cancer is an unusual disease and often goes undetected by ro...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT PHASE2 This clinical trial studies gallium Ga 68-edotreotide positron emission tom...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor PHASE3 TERAVECT is a phase III randomized study of patients with digestive neuroen...
Show More Location
Hôpital Haut Lévêque - CHU Bordeaux
Learn More & Join Trial
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors PHASE1 The investigators hypothesize that the new imaging method Gallium-68-DOTATA...
Show More Location
Nuclear Medicine, Bern University Hospital
Learn More & Join Trial
Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis NA The purpose of this research study to find out if a drug called OctreoScan ...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer PHASE2 RATIONALE: Radiolabeled drugs such as yttrium Y 90-DOTA-tyr3-octreotide can...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Combination Targeted Radiotherapy in Neuroendocrine Tumors NA The primary aim of this project is to determine, what fraction of individua...
Show More Location
University of Iowa
Learn More & Join Trial
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer PHASE1 RATIONALE: Radiation therapy uses high-energy x-rays and other sources to d...
Show More Location
Yale Comprehensive Cancer Center
Learn More & Join Trial
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors PHASE1 This protocol is designed to test the efficacy of 68Ga-DOTATOC PET/CT in di...
Show More Location
University of Iowa Health Care
Learn More & Join Trial